Global Stromal Vascular Fraction Strategic Business Report 2023: Increasing Awareness about Stem Cell Therapy Bodes Well

DUBLIN, July 11, 2023 /PRNewswire/ -- The "Stromal Vascular Fraction: Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering.

The global market for Stromal Vascular Fraction estimated at US$82.2 Million in the year 2022, is projected to reach a revised size of US$116.9 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2022-2030.

Isolation Products, one of the segments analyzed in the report, is projected to record a 4.3% CAGR and reach US$91.4 Million by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Aspiration Products segment is readjusted to a revised 5.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $29.5 Million, While China is Forecast to Grow at 5.8% CAGR

The Stromal Vascular Fraction market in the U.S. is estimated at US$29.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$9.7 Million by the year 2030 trailing a CAGR of 5.8% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Select Competitors (Total 25 Featured) -

• Cellular Biomedicines Group, Inc.
• Cytori Therapeutics, Inc.
• GE Healthcare
• Genesis Biosystems, Inc.
• Human Med AG
• InGeneron, Inc.
• KYOCERA Corporation
• Tissue Genesis Inc.

Key Attributes:

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Stromal Vascular Fraction - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• Stem Cells, Application Areas, and the Different Types: A Prelude
• Applications of Stem Cells
• Types of Stem Cells
• Stromal Vascular Fraction: An Introduction
• Production Method for SVF
• SVF Cell Procedure
• SVF Composition, Content, and Source
• SVF: Mechanism of Action
• SVF: Clinical Applications
• Safety and Efficiency of SVF
• Clinical Trials and Regulations Related to SVF
• Limitations and Scope
• Impact of Covid-19 and a Looming Global Recession
• COVID-19 Impact on Stromal Vascular Fraction Market
• GLOBAL MARKET OVERVIEW
• Extensive Therapeutic Scope Set to Stimulate Growth of Global Stromal Vascular Fraction Market
• Soft Tissue Segment Leads the Market
• North America Dominates the Global Market, Asia-Pacific to Witness Fastest Growth
• Lucrative Opportunities & Restraints
• Market Restraints
• Salient Drivers Offering Growth Impetus to Stromal Vascular Fraction Market
• Extensive Application Scope
• Rising Focus on Non-Enzymatic Isolation Techniques
• Strong Research Focus on Optimization of Tissue Recovery
• Consistent Efforts to Develop Better Cell Therapies
• Competition
• Players Bet on Product Innovation to Push Footprint in Stromal Vascular Fraction Market
• Recent Market Activity
• SVF Isolation Products Continue to Make Gains

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Regenerative Medicine: A Promising Application of Stromal Vascular Fraction
• Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
• Global Stem Cell & Regenerative Medicine Market by Product (in %) for the Year 2019
• Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2019
• Increased Prevalence of Musculoskeletal Disorders & Knee Osteoarthritis Steers Market Expansion
• Use of SVF in Osteoarthritis Treatment
• Surging Demand for Aesthetic & Reconstructive Therapies Enhances Market Prospects
• Total Number of Surgical Procedures Performed across the Globe by Plastic Surgeons (2018)
• Total Number of Surgical Procedures across the Globe by Region of the Body: 2018
• Increasing Awareness about Stem Cell Therapy Augurs Well
• Innovative Methods Become Relevant in Optimizing Tissue Recovery
• Stromal Vascular Formation Holds Significance for Chronic Diseases
• Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
• Stromal Vascular Fraction in Diabetic Care
• Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
• Low Temperature Settings Optimize Vitality of Adipose Tissue-derived SVFs
• SVF Offers Helpful Microenvironment to Regulate ASC Activity under Specific Clinical Conditions
• Swift Influx of Stem Cell Therapies Requires Alternate Regulatory Pathway Covering Autologous SVF
• The Counterview
• Contrast with Regulatory Framework Covering HCT/Ps
• Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for Stromal Vascular Fracture
• Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
• High Incidence of Neurological Disorders: A Key Market Driver
• Annual Incidence of Adult-Onset Neurologic Disorders in the US
• Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
• Increase in Healthcare Spending Stirs Demand for Stromal Vascular Formation
• World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
• Expansion of Private Hospitals in Rural Areas

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/cxevrt

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets